Citius Pharmaceuticals, Inc. (CTXR) Gross margin 2017–2019
Citius Pharmaceuticals, Inc. (CTXR) gross margin by fiscal year — reported gross profit divided by reported revenue.
16.7%FY2019 · since FY2017: 10.0% → 16.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 16.7% | -16.7 pp |
| FY2018 | 33.3% | +23.3 pp |
| FY2017 | 10.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice